DILANTIN Safety Questions, DILANTIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DILANTIN. Our extensive database of DILANTIN adverse events and DILANTIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DILANTIN
DILANTIN Safety Reports
Total DILANTIN reports: 313.DILANTIN FDA safety alerts: No.
Reported deaths: 18 Reported hospitalizations: 121.
Take DILANTIN Side Effects Survey or Share Your DILANTIN Story. Read More Here.
Showing 1-75 of 313 Next >
Consumer or non-health professional from AUSTRALIA reported DILANTIN problem on May 17, 2007. Male patient, 45 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, calcium deficiency, confusional state, conjunctival discolouration, dysarthria, fatigue, gingival swelling, neck pain, vitamin d abnormal. DILANTIN dosage: unknown. During the same period patient was treated with MYSOLINE. Patient recovered.DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 52 years of age, was diagnosed with convulsion, ebstein's anomaly and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: osteoporosis. DILANTIN dosage: unknown. During the same period patient was treated with FOSAMAX, CALCIUM CHLORIDE, VITAMIN D, LYRICA, TRIPEPTAL, PHENYTOIN, KEPPRA. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Apr 17, 2007. Female patient, weighting 104.9 lb, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, brain neoplasm, depression, somnolence. DILANTIN dosage: unknown. During the same period patient was treated with CHANTIX, TEGRETOL, LIPITOR, NEXIUM, ADVAIR DISKUS. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from AUSTRALIA on May 21, 2007. Male patient, 45 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, calcium deficiency, confusional state, conjunctival discolouration, dysarthria, fatigue, gingival swelling, hypotonia, knee deformity. DILANTIN dosage: unknown. During the same period patient was treated with MYSOLINE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on May 23, 2007. Male patient, weighting 175.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, convulsion, grand mal convulsion. DILANTIN dosage: unknown. During the same period patient was treated with PHENOBARBITAL, DEPAKOTE. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2007. Male patient, weighting 240.5 lb, was diagnosed with convulsion, depression and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, emotional disorder, fatigue, lethargy, sedation, somnolence. DILANTIN dosage: unknown. During the same period patient was treated with NEURONTIN, ATENOLOL, ZYRTEC, PROTONIX, ZETIA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on June 04, 2007. Female patient, weighting 125.0 lb, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: hodgkin's disease. DILANTIN dosage: 200 MG 1 TIME A DAY PO. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 138.0 lb, was diagnosed with convulsion, memory impairment and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, atrioventricular block, myocardial infarction. DILANTIN dosage: unknown. During the same period patient was treated with ARICEPT, NORVASC, ZOLOFT, NITROGLYCERIN, CRESTOR, ZETIA, PLAVIX, ATENOLOL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on June 07, 2007. Female patient, 58 years of age, weighting 175.3 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: dizziness, lethargy, mental status changes, nausea, therapeutic agent toxicity, vomiting. DILANTIN dosage: DILANTIN 600MG TWICE DAILY PO. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, 30 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: chills, dermatitis bullous, dysphagia, hepatitis, hypersensitivity, hypochloraemia, hypokalaemia, mouth ulceration, pain in extremity. DILANTIN dosage: TEXT:200MG AM AND 300MG AT BEDTIME. During the same period patient was treated with NEURONTIN, TRAMADOL, LEXAPRO, VICODIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on June 01, 2007. Female patient, weighting 92.59 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, therapeutic agent toxicity. DILANTIN dosage: unknown. During the same period patient was treated with PHENOBARBITAL, DIFLUCAN, NYSTATIN, DEPAKOTE, ROCEPHIN, CEREBYX, ACYCLOVIR, AZITHROMYCIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on June 04, 2007. Male patient, weighting 160.1 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, lip and/or oral cavity cancer. DILANTIN dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on May 29, 2007. Female patient, weighting 138.0 lb, was diagnosed with convulsion, memory impairment and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, atrioventricular block, myocardial infarction. DILANTIN dosage: unknown. During the same period patient was treated with ARICEPT, NORVASC, ZOLOFT, NITROGLYCERIN, CRESTOR, ZETIA, PLAVIX, ATENOLOL. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Physician from THAILAND on June 06, 2007. Male patient, 76 years of age, was diagnosed with convulsion prophylaxis and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: blister, hepatitis, hypersensitivity, infection, pruritus, rash maculo-papular. DILANTIN dosage: unknown. During the same period patient was treated with DEPAKOTE, CEFTRIAXONE, INSULIN. Patient died.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on June 06, 2007. Male patient, weighting 154.1 lb, was diagnosed with convulsion, osteoporosis and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, abnormal behaviour, anxiety, chest pain, constipation, convulsion, drooling. DILANTIN dosage: unknown. During the same period patient was treated with FOSAMAX, TOPAMAX, MIACALCIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2007. Female patient, weighting 147.0 lb, was diagnosed with convulsion, depression, panic attack, insomnia and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: depression, feeling jittery, nervousness, panic attack, prothrombin time prolonged, somnolence, thrombosis. DILANTIN dosage: unknown. During the same period patient was treated with ZOLOFT, KLONOPIN, LORAZEPAM, PHENOBARBITAL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on June 13, 2007. Female patient, weighting 155.0 lb, was diagnosed with convulsion, vertigo, thrombosis prophylaxis and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: chest pain, convulsion, facial palsy, fatigue, muscular weakness, peroneal nerve palsy, pruritus. DILANTIN dosage: unknown. During the same period patient was treated with DEPAKOTE, ATIVAN, DILAUDID, ZOLOFT, MECLIZINE, PROTONIX, HEPARIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Male patient, weighting 197.4 lb, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: body height decreased, fracture, joint injury, osteoporosis. DILANTIN dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient recovered.
Pharmacist from UNITED STATES reported DILANTIN problem on June 14, 2007. Female patient was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: fistula. DILANTIN dosage: TEXT:200MG IN AM AND 300MG IN PM. Patient recovered.
DILANTIN problem was reported by a Health Professional from UNITED STATES on June 28, 2007. Male patient, 40 years of age, weighting 160.9 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: respiratory distress, swelling face. DILANTIN dosage: ORAL;100.0 MILLIGRAM 100MG TID X 4 DOSES. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 03, 2006. Male patient, 30 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, movement disorder, myoclonus, neuroleptic malignant syndrome, tardive dyskinesia. DILANTIN dosage: 300 MG DAILY PO. During the same period patient was treated with TRILEPTAL, CALCIUM CARBONATE, MECLIZINE. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, weighting 205.0 lb, was diagnosed with grand mal convulsion, depression, arrhythmia, urinary tract infection and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, depression, diarrhoea, nausea, prostate cancer, urinary tract infection. DILANTIN dosage: 500 MG (100 MG, 3 IN 1 D), ORAL. During the same period patient was treated with CYMBALTA, PROVIGIL, AMIODARONE, ROCEPHIN, XOPONEX, LEVOTHYROXINE, LAMICTAL, BENICAR. Patient recovered.
Pharmacist from UNITED STATES reported DILANTIN problem on June 22, 2006. Female patient, 47 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion. DILANTIN dosage: 290 MG (1 D), ORAL. During the same period patient was treated with DEPAKOTE. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED KINGDOM on June 27, 2006. Female patient, 13 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: gamma-glutamyltransferase increased. DILANTIN dosage: unknown. During the same period patient was treated with VFEND. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 07, 2006. Female patient, 58 years of age, weighting 127.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, dizziness, dyspepsia, influenza. DILANTIN dosage: 300 MG (100 MG, 3 IN 1 D). During the same period patient was treated with SYNTHROID. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient, 45 years of age, was diagnosed with convulsion, infection, viral infection and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: confusional state, dysarthria. DILANTIN dosage: 300 MG QHS. During the same period patient was treated with BACTRIM, DELAVIRIDINE, TENOFAVIR, RITONAVIR. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported DILANTIN problem on July 19, 2006. Male patient, 81 years of age, was diagnosed with convulsion, hypertension and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: syncope. DILANTIN dosage: 300 MG BID. During the same period patient was treated with LISINOPRIL, PLAVIX, DILTIAZEM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Male patient, 20 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. DILANTIN dosage: 500 MG (1 D). During the same period patient was treated with KEPPRA. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 12, 2006. Male patient, 42 years of age, weighting 194.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: anxiety, convulsion, depressed mood, dizziness, haemorrhage, incorrect dose administered, influenza, loss of consciousness. DILANTIN dosage: 450 MG, ORAL. During the same period patient was treated with FLONASE, BENADRYL. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2006. Female patient, 75 years of age, weighting 112.0 lb, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PHENOBARBITAL, TOPROL, NORVASC, METHIMAZOLE, CLARINEX, COMBIVENT, ADVAIR DISKUS, ACTONEL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 14, 2006. Male patient, 74 years of age, weighting 176.0 lb, was diagnosed with convulsion, atrial fibrillation, cerebrovascular accident, urinary tract infection and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: anaemia, anuria, benign prostatic hyperplasia, candidiasis, catheter related complication, cerebral infarction, cerebrovascular accident, chest pain, convulsion. DILANTIN dosage: 400 MG 400 MG, 1 IN 1 D), ORAL. During the same period patient was treated with CEREBYX, PLAVIX, MACROBID, TAMSULOSIN, HYDROCHLOROTHIAZIDE, KEFLEX. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Male patient, child 7 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, asthma, conjunctivitis infective, dry skin, dysphagia, dysuria, eye infection, eye irritation, hordeolum. DILANTIN dosage: 150 MG (50 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ALBUTEROL, PRELONE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 15, 2006. Male patient, 53 years of age, weighting 140.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: alcohol use, cerebral atrophy, convulsion, dehydration, eating disorder, fluid retention, hepatic cirrhosis, hepatocellular damage. DILANTIN dosage: 400 MG (100 MG, FREQUENCY: QID INTERVAL: EVERY DAY) , ORAL. During the same period patient was treated with ALCOHOL, FOLIC ACID, VITAMIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, weighting 7.31 lb, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: spina bifida occulta. DILANTIN dosage: unknown. During the same period patient was treated with LAMICTAL, TOPAMAX. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Aug 03, 2006. Female patient, 45 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, deep vein thrombosis, hepatocellular damage, hepatotoxicity. DILANTIN dosage: unknown. During the same period patient was treated with LOVENOX, COUMADIN, HYDROCODONE BITARTRATE, REGLAN. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion. DILANTIN dosage: 600 MG (300 MG, 2 IN 1 D). Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 07, 2006. Male patient, 18 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: pruritus. DILANTIN dosage: 1000MG IV. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 43 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion. DILANTIN dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 09, 2006. Male patient, 54 years of age, was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, fall. DILANTIN dosage: 200 MG BID. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Male patient, 43 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, aphasia, arthralgia, asterixis, asthenia, aura, cerebral atrophy, confusional state. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D). During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 26, 2006. Male patient, 86 years of age, weighting 138.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abasia, communication disorder, coordination abnormal, dehydration, drooling, hypersensitivity, hypothermia, loss of control of legs. DILANTIN dosage: 300 MG (100 MG, DAILY). During the same period patient was treated with HYDROXYUREA, ACETYLSALICYLIC ACID SRT, VITAMIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 43 years of age, weighting 196.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abscess, condition aggravated, convulsion, insomnia, multiple allergies, pharmaceutical product counterfeit, seasonal allergy. DILANTIN dosage: unknown. During the same period patient was treated with DILANTIN KAPSEAL, VITAMIN, CALCIUM GLUCONATE, DRISDOL, FOSAMAX, PHENOBARBITAL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 01, 2006. Female patient, 57 years of age, weighting 132.0 lb, was diagnosed with partial seizures and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, thromboangiitis obliterans. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D). During the same period patient was treated with PLAVIX, AMITRIPTYLINE. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2006. Male patient, 75 years of age, was diagnosed with delirium tremens, prophylaxis and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: ecchymosis, erythema, oedema peripheral. DILANTIN dosage: unknown. During the same period patient was treated with FOLIC ACID, FAMOTIDINE, HUMULIN R, METOPROLOL TARTRATE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on July 31, 2006. Female patient, 77 years of age, was diagnosed with convulsion, amnesia, ill-defined disorder and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: asthenia, coronary artery occlusion, dizziness, embolism, fatigue, lower respiratory tract infection, transient ischaemic attack. DILANTIN dosage: 300 MG (1 IN 1 D), ORAL. During the same period patient was treated with ARICEPT, ACTONEL, PHENYTOIN, ANTICOAGULANTS, LESCOL, CALCIUM WITH VITAMIN D, COUMADIN. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 14, 2006. Female patient, 55 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: anxiety, emotional distress, fear, injury, pain, stevens-johnson syndrome. DILANTIN dosage: 400 MG (200 MG, 2 IN 12 HR), ORAL. During the same period patient was treated with VITAMIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Aug 04, 2006. Male patient was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, dialysis, hepatic failure, lethargy, pyrexia, renal failure. DILANTIN dosage: 200 MG (100 MG, 2 IN 1 D) ORAL. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Male patient, weighting 165.0 lb, was diagnosed with convulsion, grand mal convulsion, multiple allergies, rash, urticaria, ill-defined disorder and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abdominal strangulated hernia, alcohol use, alcoholism, angioneurotic oedema, arthropod sting, aura, balance disorder, condition aggravated, convulsion. DILANTIN dosage: 500 MG (2 IN 1 D) ORAL. During the same period patient was treated with DILANTIN KAPSEAL, PHENYTOIN, ZYRTEC, ALCOHOL, CALCIUM WITH VITAMIN D, DEPAKOTE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 07, 2006. Male patient, 47 years of age, weighting 166.2 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: erythema, rash. DILANTIN dosage: 400 MG. During the same period patient was treated with PHENYTOIN, PANTOPRAZOLE, QUETIAPINE, NICOTINE, LATANOPROST, DIVALPROEX, ALUMINUM HYDROXIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2006. Male patient, 74 years of age, was diagnosed with convulsion, amnesia and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: amnesia, constipation, diarrhoea. DILANTIN dosage: unknown. During the same period patient was treated with ARICEPT. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 07, 2006. Male patient, 60 years of age, weighting 185.0 lb, was diagnosed with grand mal convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: aura, convulsion, fatigue, head discomfort, headache, hyperhidrosis. DILANTIN dosage: 400 MG (100 MG, 4 IN 1 D), ORAL. During the same period patient was treated with ALLEGRA, PHENOBARBITAL, FLONASE. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on Aug 07, 2006. Male patient, 47 years of age, weighting 166.2 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: alcohol detoxification, ill-defined disorder, injection site reaction, purple glove syndrome. DILANTIN dosage: 400 MG. During the same period patient was treated with PHENYTOIN, PANTOPRAZOLE, QUETIAPINE, NICOTINE, LANTANOPROST, DIVALPROEX, ALUMINUM HYDROXIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 07, 2006. Female patient, 49 years of age, weighting 114.0 lb, was diagnosed with convulsion, mineral supplementation, ill-defined disorder and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: arthritis, convulsion, dizziness. DILANTIN dosage: 100MG AM; 230MG PM. (2 IN 1 D), ORAL. During the same period patient was treated with CITRACAL, VITAMIN, MYSOLINE, VITAMIN B6, VITAMIN E, GLUCOSAMINE W. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on Aug 22, 2006. Male patient, 62 years of age, weighting 214.0 lb, was diagnosed with convulsion prophylaxis and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood creatinine increased, chills, confusional state, malaise, pruritus, pyrexia, rash. DILANTIN dosage: 100MG TID PO. During the same period patient was treated with DOCUSATE, VICODIN, HYDROXYZINE, LORATADINE, METOPROLOL TARTRATE, PERCOCET, DIPHENHYDRAMINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Aug 10, 2006. Female patient, 75 years of age, weighting 112.0 lb, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PHENYTOIN, PHENOBARBITAL, TOPROL, NORVASC, METHIMAZOLE, CLARINEX, COMBIVENT, ADVAIR DISKUS. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on Aug 11, 2006. Male patient, weighting 150.0 lb, was diagnosed with convulsion, pain and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: back pain, body height decreased, contusion, convulsion, coronary artery bypass, diarrhoea, gastritis erosive. DILANTIN dosage: 100 MG. During the same period patient was treated with MOTRIN, ROBAXIN, SKELAXIN, VICODIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 14, 2006. Female patient was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, disorientation, dizziness, myocardial infarction, therapeutic agent toxicity, toe operation. DILANTIN dosage: 30 MG. During the same period patient was treated with DEMEROL, WELLBUTRIN. Patient died.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Female patient, 37 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: intervertebral disc protrusion, skin ulcer. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D). Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 15, 2006. Female patient, 52 years of age, was diagnosed with grand mal convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: cerebral artery occlusion, cerebrovascular accident, convulsion, grand mal convulsion, treatment noncompliance. DILANTIN dosage: 300 MG, ORAL. During the same period patient was treated with KEPPRA, AMITRIPTYLINE. Patient was hospitalized. Patient died on 07/01/2006.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Male patient, 70 years of age, weighting 175.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion. DILANTIN dosage: 400 MG (400 MG, 1 IN 1 D). Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 16, 2006. Female patient, 67 years of age, weighting 150.0 lb, was diagnosed with convulsion, rash and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: burning sensation, rash pruritic. DILANTIN dosage: 300 MG (300 MG,1 IN 1 D). During the same period patient was treated with BENADRYL CREAM, ATENOLOL. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2006. Male patient, 66 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, skin disorder. DILANTIN dosage: 600 MG (1 IN 1 D). During the same period patient was treated with DILANTIN W, CELEBREX, VIOXX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 18, 2006. Male patient, 65 years of age, weighting 184.0 lb, was diagnosed with grand mal convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, disease recurrence. DILANTIN dosage: 230 MG (2 IN 1 D). During the same period patient was treated with LAMICTAL, LEXAPRO, WELLBUTRIN. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED KINGDOM on Aug 23, 2006. Male patient was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: convulsion, dysphagia. DILANTIN dosage: 350 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 23, 2006. Male patient, 81 years of age, weighting 183.0 lb, was diagnosed with grand mal convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, cataract, convulsion, dysuria, prostate examination abnormal, treatment noncompliance. DILANTIN dosage: 400 MG (100 MG, 4 IN 1 D). During the same period patient was treated with PHENYTOIN, XALATAN. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from CANADA on Aug 23, 2006. Male patient, 44 years of age, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: gingival disorder, malaise, tooth disorder, tooth loss, vomiting. DILANTIN dosage: (100 MG). During the same period patient was treated with TEGRETOL, VALPROIC ACID, ZYPREXA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DILANTIN problem on Aug 25, 2006. Male patient, child 11 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: dry skin, eye movement disorder, keratoconjunctivitis sicca, scar, skin discolouration, stevens-johnson syndrome, visual acuity reduced. DILANTIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2006. Male patient, child 11 years of age, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: dry skin, keratoconjunctivitis sicca, pyrexia, rash, scar, skin discolouration, stevens-johnson syndrome. DILANTIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 22, 2006. Female patient, 27 years of age, was diagnosed with epilepsy and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: premature separation of placenta. DILANTIN dosage: 500 MG, ORAL. During the same period patient was treated with DEPAKOTE. Patient died.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Male patient, child 7 years of age, weighting 63.00 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, asthma, conjunctivitis infective, dysphagia, dysuria, grand mal convulsion, hordeolum, keratitis. DILANTIN dosage: 150 MG (50 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ALBUTEROL, PRELONE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Aug 22, 2006. Male patient, 43 years of age, weighting 220.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, amnesia, arthralgia, asterixis, aura, central nervous system lesion, cerebral atrophy, computerised tomogram abnormal. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D). During the same period patient was treated with DIVALPROEX. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Male patient, child 7 years of age, weighting 63.00 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, asthma, condition aggravated, conjunctivitis infective, dysphagia, dysuria, eye pain, eyelid margin crusting. DILANTIN dosage: 150 MG (50 MG, 3 IN 1 D), ORAL. During the same period patient was treated with ALBUTEROL, PRELONE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported DILANTIN problem on Aug 22, 2006. Male patient, 43 years of age, weighting 220.0 lb, was diagnosed with convulsion and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, arthralgia, asterixis, aura, central nervous system lesion, cerebral atrophy, condition aggravated, confusional state. DILANTIN dosage: 300 MG (300 MG, 1 IN 1 D). During the same period patient was treated with DILVALPROEX. Patient was hospitalized. Patient recovered.
DILANTIN problem was reported by a Pharmacist from UNITED STATES on Aug 24, 2006. Female patient, 87 years of age, was diagnosed with constipation and was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. DILANTIN dosage: unknown. During the same period patient was treated with ASPIRIN, POLYETHYLENE GLYCOL, METAMUCIL, ALPRAZOLAM, DARVOCET, ZELNORM. Patient recovered.
Health Professional from UNITED STATES reported DILANTIN problem on Aug 22, 2006. Female patient was treated with DILANTIN. After drug was administered, patient experienced the following problems/side effects: maternal condition affecting foetus, premature separation of placenta. DILANTIN dosage: unknown. During the same period patient was treated with DEPAKOTE. Patient died on 10/07/2001.
Showing 1-75 of 313 Next >
This
drug has an active FDA Safety Alert